Evidence map›Paper›PMID 34326259›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Soluble mannose receptor induces proinflammatory macrophage activation and metaflammation.

Maria Embgenbroich, Hendrik J P van der Zande, Leonie Hussaarts, Jonas Schulte-Schrepping, Leonard R Pelgrom, Noemí García-Tardón, Laura Schlautmann, Isabel Stoetzel, Kristian Händler, Joost M Lambooij and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. NLRP3 inflammasome activity and pyroptosis are involved in CD206Acta biochimica et biophysica Sinica · 2025
    Article
  9. Article
  10. Article
  11. Mannosamine-Modified Poly(lactic-Bioconjugate chemistry · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. CD206BMC immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 2 institutions in 3 countries.

Maria EmbgenbroichCellular Immunology, Life and Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany.ORCID 0000-0001-9954-1859
Hendrik J P van der ZandeDepartment of Parasitology, Leiden University Medical Center, 2333ZA Leiden, The Netherlands.ORCID 0000-0003-1479-1934
Leonie HussaartsDepartment of Parasitology, Leiden University Medical Center, 2333ZA Leiden, The Netherlands.
Jonas Schulte-SchreppingGenomics and Immunoregulation, Life and Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany.
Leonard R PelgromDepartment of Parasitology, Leiden University Medical Center, 2333ZA Leiden, The Netherlands.
Noemí García-TardónDepartment of Parasitology, Leiden University Medical Center, 2333ZA Leiden, The Netherlands.
Laura SchlautmannCellular Immunology, Life and Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany.ORCID 0000-0001-8850-9087
Isabel StoetzelCellular Immunology, Life and Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany.ORCID 0000-0001-6326-1409
Kristian HändlerPlatform for Single-Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases and University of Bonn, 53115 Bonn, Germany.
Joost M LambooijDepartment of Parasitology, Leiden University Medical Center, 2333ZA Leiden, The Netherlands.ORCID 0000-0002-4853-5843
Anna Zawistowska-DeniziakDepartment of Parasitology, Leiden University Medical Center, 2333ZA Leiden, The Netherlands.ORCID 0000-0001-6990-9165
Lisa HovingDepartment of Human Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Karin de RuiterDepartment of Parasitology, Leiden University Medical Center, 2333ZA Leiden, The Netherlands.
Marjolein WijngaardenDepartment of Internal Medicine, Section Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0002-4697-0286
Hanno PijlDepartment of Internal Medicine, Section Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Ko Willems van DijkDepartment of Human Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Bart EvertsDepartment of Parasitology, Leiden University Medical Center, 2333ZA Leiden, The Netherlands.ORCID 0000-0002-3764-5131
Vanessa van HarmelenDepartment of Human Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Maria YazdanbakhshDepartment of Parasitology, Leiden University Medical Center, 2333ZA Leiden, The Netherlands.
Joachim L SchultzeGenomics and Immunoregulation, Life and Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany.
Bruno GuigasDepartment of Parasitology, Leiden University Medical Center, 2333ZA Leiden, The Netherlands; b.g.a.guigas@lumc.nl burgdorf@uni-bonn.de.ORCID 0000-0002-8856-5799
Sven BurgdorfCellular Immunology, Life and Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany; b.g.a.guigas@lumc.nl burgdorf@uni-bonn.de.
Leiden University Medical Center · NLUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proinflammatory activation of macrophages in metabolic tissues is critically important in the induction of obesity-induced metaflammation. Here, we demonstrate that the soluble mannose receptor (sMR) plays a direct functional role in both macrophage activation and metaflammation. We show that sMR binds CD45 on macrophages and inhibits its phosphatase activity, leading to an Src/Akt/NF-κB-mediated cellular reprogramming toward an inflammatory phenotype both in vitro and in vivo. Remarkably, increased serum sMR levels were observed in obese mice and humans and directly correlated with body weight. Importantly, enhanced sMR levels increase serum proinflammatory cytokines, activate tissue macrophages, and promote insulin resistance. Altogether, our results reveal sMR as regulator of proinflammatory macrophage activation, which could constitute a therapeutic target for metaflammation and other hyperinflammatory diseases.

Indexed as

Animal FeedAnimalsCells, CulturedCytokinesDiet, High-FatGastrointestinal MicrobiomeGene Expression RegulationInflammationMacrophage ActivationMacrophagesMaleMannose ReceptorMembrane ProteinsMiceMice, KnockoutRandom AllocationCytokinesFcmr protein, mouseMannose ReceptorMembrane Proteinsimmunometabolismmacrophagemannose receptormetaflammationobesity

Identifiers

PMID34326259
PMCPMC8346872
OpenAlexW3186108495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.